p66Shc as the engine of vascular aging

Current Vascular Pharmacology

Volumn 10, Issue 6, 2012, Pages 697-699

  Paneni, Francesco ^a   Cosentino, Francesco ^b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aging; Endothelial dysfunction; Oxidative stress; P66Shc

Indexed keywords

FREE RADICAL; PROTEIN P66; REACTIVE OXYGEN METABOLITE; SCAVENGER;

AGING; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; GLUCOSE METABOLISM; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

AGE FACTORS; AGING; ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK FACTORS; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84870179753     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016112803520747     Document Type: Article

References (34)

1. Voelker R. IOM: focus on care for aging population. JAMA 2008; 299: 2611-3.
2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke statistics Subcommittee. Circulation 2008; 117: e25-e146.
3. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21: 518-24.
4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
5. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-76.
6. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003; 107: 490-7.
7. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003; 107: 346-54.
8. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 2003; 107: 139-46.
9. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-53.
10. Yildiz O. Vascular smooth muscle and endothelial function in aging. Ann NY Acad Sci 2007; 1100: 353-60.
11. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 266-74.
12. Tschudi MR, Barton M, Bersinger NA, et al. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 1996; 98: 899-905.
13. Barton M, Cosentino F, Brandes RP, et al. Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 1997; 30: 817-24.
14. Cernadas MR, Sanchez de Miguel L, Garcia-Duran M, et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 1998; 83: 279-86.
15. van der Loo B, Labugger R, Skepper JN, et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000; 192: 1731-44.
16. Csiszar A, Ungvari Z, Edwards JG, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002; 90: 1159-66.
17. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271(5 Pt 1): C1424-1437.
18. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268(5 Pt 1): L699-722.
19. Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 2002; 54: 619-34.
20. Zou M, Martin C, Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem 1997; 378: 707-13.
21. Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402: 309-13.
22. Francia P, delli Gatti C, Bachschmid M, et al. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 2004; 110: 2889-95.
23. Yan ZQ, Sirsjo A, Bochaton-Piallat ML, et al. Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler Thromb Vasc Biol 1999; 19: 2854-62.
24. Cosentino F, Francia P, Camici GC, Pelicci PG, Volpe M, Luscher TF. Final common molecular pathways of aging and cardiovascular disease. Role of p66Shc protein. Atheroscl Thromb Vasc Biol 2008; 28: 622-8.
25. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998; 21 (Suppl 3): C11-C14.
26. Howard BV, Wylie-Rosett J. Sugar and cardiovascular disease: A statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 2002; 106: 523-7.
27. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990; 85: 929-32.
28. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695-701.
29. Cosentino F, Eto M, De Paolis P, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 2003; 107: 1017-23.
30. Guzik TJ, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656-62.
31. Paneni F, Cosentino F, Passerini J, Volpe M. Is there any memory effect of blood pressure lowering in diabetes? Int J Cardiol 2011; 151: 384-5.
32. Camici GG, Schiavoni M, Francia P, et al. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA 2007; 104: 5217-22.
33. Nemoto S, Combs CA, French S, et al. The mammalian longevityassociated gene product p66shc regulates mitochondrial metabolism. J Biol Chem 2006; 281: 10555-60.
34. Pagnin E, Fadini G, de Toni R, Tiengo A, Calo L, Avogaro A. Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab 2005; 90: 1130-6.